Published date: Oct 25 2021

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: October–December 2021, Volume 16, Issue 4

Pages: 527–530

DOI: 10.18502/jovr.v16i4.9740

Seyed-Hossein AbtahiOphthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Hosein NouriOphthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Siamak MoradianMoradian33195@yahoo.comOphthalmic Epidemiology Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Shahin YazdaniOphthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Hamid AhmadiehOphthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran

This is an Editorial and does not have an abstract. Please download the PDF or view the article HTML.

Keywords: Not applicable

1. Banoun H. Evolution of SARS-CoV-2: review of mutations, role of the host immune system. Nephron 2021;145:392–403.

2. Roshanshad A, Ali Ashraf M, Roshanshad R, Kharmandar A, Alireza Zomorodian S, Ashraf H. Ocular manifestations of patients with coronavirus disease 2019: a comprehensive review. J Ophthalmic Vis Res 2021;16:234–247.

3. Dumitrascu OM, Volod O, Bose S, Wang Y, Biousse V, Lyden PD. Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. J Stroke Cerebrovasc Dis 2020;29:104982.

4. Raevis JJ, Gjyzeli G, Mititelu M, Rogers J, Lasarev M, Chang JS. Face masks and bacterial dispersion toward the periocular area. Ophthalmology 2021;128:1236–1238.

5. Marin-Nieto J, Reino-Perez C, Santillana-Cernuda G, Díaz-Bernal JM, Luque-Aranda R, García-Basterra I. Face mask contamination during COVID-19 pandemic. Study on patients receiving intravitreal injections. Retina 2021; Online ahead of print.

6. Lawrenson JG, Buckley RJ. COVID-19 and the eye. Ophthalmic Physiol Opt 2020;40:383–388.

7. Parke DW. Ophthalmology after coronavirus disease 2019 (COVID-19). JAMA Ophthalmol 2020;138:599.

8. Berkenstock MK, Liberman P, McDonnell PJ, Chaon BC. Changes in patient visits and diagnoses in a large academic center during the COVID-19 pandemic. BMC Ophthalmol 2021;21:139.

9. Dexamethasone in Hospitalized Patients with Covid- 19. N Engl J Med 2021;384:693–704.

10. Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf 2016;15:457–465.

11. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007;23:403–420.

12. Mohan R, Muralidharan AR. Steroid induced glaucoma and cataract. Indian J Ophthalmol 37:13–16.

13. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009;68:1119–1124.

14. Richardson RB, Ainsbury EA, Prescott CR, Lovicu FJ. Etiology of posterior subcapsular cataracts based on a review of risk factors including aging, diabetes, and ionizing radiation. Int J Radiat Biol 2020;96:1339– 1361.

15. Clark A, Morlet N, Ng JQ, Preen DB, Semmens JB. Risk for retinal detachment after phacoemulsification. Arch Ophthalmol 2012;130:882.

16. Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res 2012;47:66– 80.

17. Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, Mastropasqua L, et al. Steroidinduced glaucoma: epidemiology, pathophysiology, and clinical management. Surv Ophthalmol 2020;65:458–472.

18. Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract 2009;15:469–474.

19. Matsumoto K, Yamasaki H, Akazawa S, Sakamaki H, Ishibashi M, Abiru N, et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab 1996;81:2621–2626.

20. Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev 2014;30:96–102.

21. Homayounieh F, Holmberg O, Umairi R Al, Aly S, Basevičius A, Costa PR, et al. Variations in CT utilization, protocols, and radiation doses in COVID-19 pneumonia: results from 28 countries in the IAEA study. Radiology 2021;298:E141–E151.

22. Hauptmann M, Daniels RD, Cardis E, Cullings HM, Kendall G, Laurier D, et al. Epidemiological studies of low-dose ionizing radiation and cancer: summary bias assessment and meta-analysis. JNCI Monogr 2020;2020:188–200.

23. Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30:369–384.

24. Pandya A, Lodha P. Social connectedness, excessive screen time during COVID-19 and mental health: a review of current evidence. Front Hum Dyn 2021;3.

25. Wong CW, Tsai A, Jonas JB, Ohno-Matsui K, Chen J, Ang M, et al. Digital screen time during the COVID- 19 pandemic: risk for a further myopia boom? Am J Ophthalmol 2021;223:333–337.

26. Kamiya K, Igarashi A, Hayashi K, Negishi K, Sato M, Bissen-Miyajima H. A multicenter prospective cohort study on refractive surgery in 15011 eyes. Am J Ophthalmol 2017;175:159–168.

27. Berkowitz ST, Sternberg P, Patel S. Cost analysis of routine vitrectomy surgery. Ophthalmol Retin 2021;5:496–502.